Bausch & Lomb
This article was originally published in The Gray Sheet
Executive Summary
Divestiture of a majority interest in its Charles River Laboratories research laboratory animal and service business to DLJ Merchant Banking Partners II is complete, B&L announces Sept. 29. Under the terms of the deal B&L retains a 12.5% interest in the business and receives a $400 mil. cash payment and a $43 mil. promissory note. Charles River is B&L's last non-core business to be divested as the firm refocuses on healthcare for the eye